Klatte et al. used tissue microarray technology to determine the correlation between the expressions of Ki-67, p53, VEGFR-1 and VEGF-D with ccRCC patient survival time, and constructed a prognostic model in combination with other clinical factors [65]. Here, VEGFD is linked to nonpapillary renal cell carcinoma.